
Cogent Biosciences, Inc.
USD39.64
+1.34 (+3.50%)
CEO
Andrew R. Robbins
IPO Date
2018-03-29
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$38.36
Prev. Close
$38.30
Day Low
$38.22
Day High
$39.80
52W Low
$10.38
52W High
$43.73
Market Cap
$6.77B
Volume
1.19M
| 18 Feb 2026 |
| Piper Sandler |
| Overweight |
| Overweight |
| maintain |
| 21 Jan 2026 | Wedbush | Outperform | Outperform | maintain |
| 6 Jan 2026 | HC Wainwright & Co. | Buy | Buy | maintain |
| 19 Dec 2025 | JP Morgan | Overweight | Overweight | maintain |
| 8 Dec 2025 | Needham | Hold | Hold | maintain |
| 13 Nov 2025 | HC Wainwright & Co. | Buy | Buy | maintain |
| 11 Nov 2025 | Baird | Neutral | Neutral | maintain |